Life Sci AI: The Podcast SciPro

After more than 10 years as a powerhouse in DTx it was a pleasure to have Kim join us on the podcast. Kim Baden-Kristensen is the CEO and Co-Founder of Brain+. A company based in Copenhagen that are seeking to meet the challenge of Dementia and Alzheimer's care by harnessing the power of technology and AI. In this episode, we take a deep dive into his career, his purpose and what Brain+ have achieved, achieving and seeking to achieve.


Enjoy the episode.

LLMs in healthcare.

This is the episode we finally tackled the topic in depth. In
this episode Nick is joined by the CTO and Co-Founder of Alex Therapeutics, Oliver Fleetwood.

Not only do they discuss the technology behind the fantastic
Alex product and future products but they tackle the readiness of patients and regulatory bodies for LLMs to be used in mental health care.

This is a super exciting episode so enjoy!

The second episode of series 5 delves into building a MedTech start-up with purpose.



Nick Mahoney is joined by CEO of Sonio, Cecile Dubois. Sonio is an AI-software guiding practitioners during prenatal ultrasound scans to secure prenatal screening and optimize prenatal diagnosis.



In this episode, Nick unpacks the technology behind the amazing product and how Cecile has balanced building a diverse company with industry expertise.

In the first episode of series five, host Nick Mahoney was joined by the CCO of Doccla, Tom Breeze. For the first time in our podcast studio, Nick and Tom discuss the transition he made from private equity to healthcare and what drives him about the mission of Doccla.



Situated in an exciting period of growth for Doccla, this is great episode to learn more about remote patient monitoring systems and the go to market strategies needed across different locations.

In this episode Nick and Jon discuss the future of hiring into Computational Chemistry teams and how the use of AI is affecting this. A topic Nick spoke at great length about at the #aisummit also. Jon has been through many technological changes in the industry and so his expertise and knowledge shines through with some great nuggets of information.

Jon Heal is the Silico team (also known as prosaRx) leader at RxCelerate which is a rapidly growing company conducting service based work for drug discovery programs based in Cambridge, UK. Jon was previously a co-founder of Prosarix Ltd and Head of Computational Chemistry at Evolva SA, a swiss biotech company focussing on innovative approaches within synthetic biology space. Jon has over 20 years experience of drug discovery, was instrumental in the development of the ProtoDiscovery™ technology platform and its application in over 50 drug discovery projects with many different client companies.

To speak to Nick, please drop an email to n.mahoney@sciproglobal.com

Following the successful conclusion of another JP Morgan Conference in 2023, Nick sat down with Dr Juana Candia to hear about her take on this year's conference and what we should take from it.

Juana brings more than 20 years of leadership experience in Biotech, Precision Medicine, and Cell & Gene Therapy. She is the co-founder of one of the first Biotech startups in South America, pursued scientific discoveries and built businesses in seven countries and four continents. Accelerated innovation pipelines, authored 20+ patents families, designed, and delivered growth strategies resulting in business turnarounds and double-digit growths while working for Roche, DSM, Novartis, GSK, and Scailyte (Start-up). Currently serving on Boards of Directors and Advisers to emerging companies with transformative technologies and disruptive business models.

To speak to Nick, please drop an email to n.mahoney@sciproglobal.com